As a team of neurosurgeons, scientists, and entrepreneurs, we founded Belay Diagnostics to help those with suspected brain tumors find the right path forward. Given the drawbacks of traditional methods in detecting central nervous system malignancies, we see our proprietary molecular testing technology as a way to bridge the gap between current standards and the imperative of informing diagnosis with clinically significant, patient-centric genomic insights.